TipRanks
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market
VRAX
Virax Biolabs Group Ltd. Class A
RESEARCH TOOLSreports

Virax Biolabs Group Ltd. Class A (VRAX) Income Statement

171 Followers

Virax Biolabs Group Ltd. Class A Income Statement

Last quarter (Q4 2026), Virax Biolabs Group Ltd. Class A's total revenue was $12.42K, a decrease of -84.46% from the same quarter last year. In Q4, Virax Biolabs Group Ltd. Class A's net income was $-5.02M. See Virax Biolabs Group Ltd. Class A’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Sep 22
Total Revenue
$ 12.42K$ 6.33K$ 156.42K-$ 0.00
Gross Profit
$ 7.69K$ -53.07K$ 50.59K-$ 0.00
Operating Expenses
$ 6.41M$ 6.11M$ 6.55M$ 5.73M$ 1.73M
Depreciation and Amortization
$ 439.02K$ 343.39K$ 103.10K$ 1.00$ 1.73M
EBITDA
$ -5.43M$ -5.80M$ -6.61M$ -5.44M$ -750.00
Operating Income
$ -6.40M$ -6.16M$ -6.50M$ -5.73M$ -1.73M
Other Income/Expenses
$ 467.31K$ -41.00K$ -242.65K$ 275.00K$ -16.19K
Pretax Income
$ -5.93M$ -6.20M$ -6.74M$ -5.46M$ -1.75M
Net Income
$ -5.02M$ -6.06M$ -6.73M$ -5.46M$ -1.71M
Per Share Metrics
Basic EPS
$ -12.64$ -49.00$ -84.00$ -128.25$ -37.50
Diluted EPS
$ -12.64$ -48.75$ -84.00$ -128.25$ -37.50
Weighted Average Shares Outstanding
 397.59K 123.88K 80.26K 42.52K 45.50K
Weighted Average Shares Outstanding (Diluted)
 397.59K 124.14K 80.26K 42.52K 45.50K
Currency in USD

Virax Biolabs Group Ltd. Class A Earnings and Revenue History